Academic Bibliography

Search 200 years of publications by Ghent University researchers.

dr. Sandra Van Lint

Faculty of Medicine and Health Sciences > Department of Biomolecular Medicine

Work address: Albert Baertsoenkaai 3
9000 Gent
Email: Sandra.VanLint@UGent.be

Show Sort by

Add to list
- Conference Paper
- C3
Towards the use of interleukin-1β as vaccine adjuvant

Bram Van Den Eeckhout (UGent) , Lien Van Hoecke (UGent) , Elianne Burg (UGent) , Sandra Van Lint (UGent) , Frank Peelman (UGent) , Xavier Saelens (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2019) The 1918 influenza pandemic: historical and biomedical reflections, VIB conference, Abstracts.
Add to list
Targeting interferon activity to dendritic cells enables in vivo tolerization and protection against EAE in mice

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Dominiek Catteeuw (UGent) , Shengru Pang, Franciane Paul, Elke Rogge (UGent) , Annick Verhee (UGent) , Marco Prinz, Niko Kley, Gilles Uzé, et al.

(2019) JOURNAL OF AUTOIMMUNITY. 97. p.70-76
Add to list
- Conference Paper
- C3
IL-1β AcTaleukins : towards potent yet safe adjuvants for tumor vaccination

Bram Van Den Eeckhout (UGent) , Elianne Burg (UGent) , Anje Cauwels (UGent) , Frank Peelman (UGent) , Sandra Van Lint (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2018) Dendritic Cells, 15th International symposium, Abstracts.
Add to list
Nanoparticle-conjugate TLR7/8 agonist localized immunotherapy provokes safe antitumoral responses

Lutz Nuhn (UGent) , Stefaan De Koker (UGent) , Sandra Van Lint (UGent) , Zifu Zhong (UGent) , João Portela Catani (UGent) , Francis Combes (UGent) , Kim Deswarte (UGent) , Yupeng Li, Bart Lambrecht (UGent) , Stefan Lienenklaus, et al.

(2018) ADVANCED MATERIALS. 30(45).
Add to list
- Journal Article
- A1
- open access
Treatment with mRNA coding for the necroptosis mediator MLKL induces antitumor immunity directed against neo-epitopes

Lien Van Hoecke (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Alexander Van Parys (UGent) , Peter Vandenabeele (UGent) , Johan Grooten (UGent) , Jan Tavernier (UGent) , Stefaan De Koker (UGent) and Xavier Saelens (UGent)

(2018) NATURE COMMUNICATIONS. 9.
Add to list
Delivering type I interferon to dendritic cells empowers tumor eradication and immune combination treatments

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Franciane Paul, Genevieve Garcin, Stefaan De Koker (UGent) , Alexander Van Parys (UGent) , Thomas Wüest (UGent) , Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yan Bordat, et al.

(2018) CANCER RESEARCH. 78(2). p.463-474
Add to list
- Conference Paper
- C3
IL-1β AcTaleukins : towards potent yet safe adjuvants for tumor vaccination

Bram Van Den Eeckhout (UGent) , Elianne Burg (UGent) , Anje Cauwels (UGent) , Frank Peelman (UGent) , Sandra Van Lint (UGent) , Jan Tavernier (UGent) and Sarah Gerlo (UGent)

(2017) Defence is the best attack : immuno-oncology breakthroughs, EACR conference, Abstracts.
Add to list
A safe and highly efficient tumor-targeted type I interferon immunotherapy depends on the tumor microenvironment

Anje Cauwels (UGent) , Sandra Van Lint (UGent) , Geneviève Garcin, Jennyfer Bultinck (UGent) , Franciane Paul, Sarah Gerlo (UGent) , José Van Der Heyden (UGent) , Yann Bordat, Dominiek Catteeuw (UGent) , Lode De Cauwer (UGent) , et al.

(2017) ONCOIMMUNOLOGY. 7(3).
Add to list
Type I interferons interfere with the capacity of mRNA lipoplex vaccines to elicit cytolytic T cell responses

Ans De Beuckelaer (UGent) , Charlotte Pollard (UGent) , Sandra Van Lint (UGent) , Kenny Roose (UGent) , Lien Van Hoecke (UGent) , Tom Naessens (UGent) , Vimal Kumar Udhayakumar (UGent) , Muriel Smet (UGent) , Niek Sanders (UGent) , Stefan Lienenklaus, et al.

(2016) MOLECULAR THERAPY. 24(11). p.2012-2020
Add to list
- Journal Article
- A1
Intratumoral delivery of TriMix mRNA results in T-cell activation by cross-presenting dendritic cells

Sandra Van Lint (UGent) , Dries Renmans, Katrijn Broos, Lode Goethals, Sarah Maenhout, Daphné Benteyn, Cleo Goyvaerts, Stephanie Dufour, Kevin Van Der Jeught, Lukasz Bialkowski, et al.

(2016) CANCER IMMUNOLOGY RESEARCH. 4(2). p.146-156

1
2
3
4

Next →